Login Join us
BACK

Popular

Showing items 91-100 of 100

Articles & Guides
IRS Provides Routine Update of ACA Penalty Amounts for Calendar Year 2025

Topic: Policy & Advocacy

Tags: Affordable Care Act (ACA),

Innovation Showcase Recap: Ketamine and Psychedelics for Mental Health

Topic: Benefits Strategy

Tags: Virtual Solutions, Mental and Emotional Well-being,

Articles & Guides
Global Brokers Call Summary: Statement of Work

Topic: Global

Tags: Global Benefits Management,

Policy & Advocacy
Business Group and Other Stakeholders Request Guidance on HDHP Status and Pre-Deductible Preventive Care

Topic: Policy & Advocacy

Tags: Pharmacy/Prescription Drugs,

Policy & Advocacy
Comments to CMS on a 2020 Proposed Medicare Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Other Issues

Topic: Policy & Advocacy

Tags: Payment & Delivery Reform,

Articles & Guides
What Your CEO is Reading: Potential Impact of Alleged Generic Price Fixing

Topic: Policy & Advocacy

Tags: Pharmacy/Prescription Drugs,

Policy & Advocacy
Business Group Statement for the Record on Employer Plan Innovation for House Education and the Workforce Committee Hearing

Topic: Policy & Advocacy

Tags: Consumerism and Transparency, Plan Design & Administration, Health Care Antitrust, Payment & Delivery Reform, Transparency,

Policy & Advocacy
Comment Letter on 2021 Notice of Benefit and Payment Parameters

Topic: Policy & Advocacy

Tags: Pharmacy/Prescription Drugs,

Policy & Advocacy
Senate Bill Would Impose 3-Day Limit on Initial Opioid Scripts

Topic: Policy & Advocacy

Tags: Leave Policy,

Policy & Advocacy
House Energy and Commerce Committee Passes 6 Bills Aimed at Increasing Generic Drug Competition

Topic: Policy & Advocacy

Tags: Pharmacy/Prescription Drugs,

Showing items91-100 of 100